Related Experiment Videos
Enterococcal bacteremia in a medical intensive care unit
1Medical ICU, Hôpital de Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, France.
Critical Care Medicine
|February 1, 1988
Summary
Enterococcal bacteremia in intensive care units (ICUs) affects predisposed patients, often linked to prior antibiotic use and prolonged hospital stays. Prompt, appropriate antibiotic therapy and identifying the infection source significantly reduce mortality.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Enterococcal bacteremia is a significant concern in intensive care units (ICUs).
- Nosocomial infections and prior antibiotic exposure are common in affected patients.
- Identifying risk factors and outcomes is crucial for patient management.
Purpose of the Study:
- To retrospectively analyze cases of enterococcal bacteremia in a medical ICU.
- To identify patient characteristics and factors associated with mortality.
- To inform prompt and appropriate treatment strategies.
Main Methods:
- Retrospective review of 35 enterococcal bacteremia cases from 1982-1984 in a medical ICU.
- Analysis of patient demographics, previous treatments, infection sources, and outcomes.
- Comparison of mortality rates based on identified factors.
Main Results:
- 27 out of 35 patients acquired nosocomial enterococcal bacteremia, with a mean prior hospital stay of 17 days.
- 13 patients had serious debilitating diseases, and 20 received prior antibiotic therapy.
- Mortality was lower in cases with identified infection sources, appropriate early antibiotic therapy, and without debilitation.
Conclusions:
- Certain patient groups in medical ICUs are predisposed to enterococcal bacteremia.
- Prompt initiation of appropriate antibiotic therapy for Enterococcus is vital, especially for infections without an obvious source.
- Identifying the infection focus and managing debilitating conditions are key to improving outcomes.